Skip to content
Login Register

#medical treatment

2 public questions tagged with this topic.

Vaccine

A vaccine is best defined as:

A vaccine is best defined as immuno-biological product containing all or part of microorganism or its products, synthetic or recombinant antigens, mRNA or viral vector engineered to express antigen, formulated to induce active acquired protective immunity against specific infectious disease or tumor without causing disease itself. It comprises immunogenic principle plus diluents, stabilizers such as sucrose, surfactants, buffers maintaining pH, preservatives like 2-phenoxyethanol preventing bacterial contamination in multidose vials, and sometimes adjuvants aluminum salts, MF59, AS01 enhancing innate activation. Quality attributes include potency measured by in vitro ELISA or in vivo challenge, sterility, purity, safety, absence of extraneous agents. Unlike antibiotics that directly kill bacteria by targeting cell wall synthesis, antibiotics are therapeutic chemotherapeutics, vaccines prophylactic training host defense. Mechanism involves antigen presentation, germinal center formation, affinity maturation, memory generation measurable as neutralizing antibody titer correlate of protection. Vaccines classified prophylactic preventing infection, therapeutic treating existing disease like therapeutic cancer vaccines targeting neoantigens. Definition emphasizes immunity induction rather than direct pathogen killing, distinguishing immunobiological from chemical drug or metabolic inhibitor categories.

Ref: WHO Vaccine definition; Plotkin Vaccines 7th ed Ch 1 immunobiological; CDC NIP.

View Details
Gene Therapy

Gene therapy is defined as:

Gene therapy uses nucleic acids themselves as therapeutic agents to correct aberrant cellular function. Rather than supplying recombinant proteins or small molecules, functional DNA, mRNA, antisense oligonucleotides, or siRNAs are delivered intracellularly. Vectors derived from AAV, lentivirus, adenovirus, or synthetic ionizable lipid nanoparticles shield cargo from serum nucleases and facilitate endocytosis via heparan sulfate receptors and endosomal escape. Once in the nucleus, expression cassette comprising promoter, codon-optimized open reading frame, and polyadenylation signal undergoes transcription by RNA polymerase II, mRNA processing, nuclear export via NXF1, and translation producing proteins such as adenosine deaminase, factor IX, or CFTR channel. Alternatively, siRNA loads into Argonaute within RISC to cleave pathogenic transcripts, while antisense blocks splicing. Durable episomal persistence or stable chromosomal integration ensures long-term correction, addressing monogenic disorders at molecular root rather than symptomatically managing phenotype with frequent protein replacement. This mechanistic insight guides vector optimization, dosing strategies, and clinical safety monitoring essential for translational development and regulatory evaluation.

Ref: NCBI Bookshelf Gene Therapy Overview Ch 9, https://www.ncbi.nlm.nih.gov/books/NBK21882/; Alberts Mol Biol Cell 6thed Chap 8.

View Details